Safe neoadjuvant trastuzumab-based treatment in HER2 + inflammatory early breast cancer in a glucose 6-phosphate dehydrogenase-deficient postmenopausal woman: A case report and review of the literature:

Alberto Jacobo Cunquero Tomás,Claudio D Ávila-Andrade,Javier Milara,Karla Javier,Vega Iranzo,Carlos Camps

Safe neoadjuvant trastuzumab-based treatment in HER2 + inflammatory early breast cancer in a glucose 6-phosphate dehydrogenase-deficient postmenopausal woman: A case report and review of the literature:

2019

Alberto Jacobo Cunquero Tomás
Claudio D Ávila-Andrade
Javier Milara
Karla Javier
Vega Iranzo
Carlos Camps

IntroductionGlucose 6-phosphate dehydrogenase (G6PD) is a basic antioxidant pathway for erythrocytes, being its deficiency the most common gene mutation worldwide. As breast cancer is one of the mo...

Keywords:

Gene
Dehydrogenase
Anesthesia
Breast cancer
Trastuzumab
Glucose-6-phosphate dehydrogenase
Oncology
Antioxidant
Internal medicine
Medicine
Mutation
early breast cancer
common gene

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations